What PCOS actually is
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting approximately 8–13% of women globally. Despite the name focusing on ovarian cysts, the primary pathology is:
- Insulin resistance: Present in 70–80% of PCOS patients regardless of body weight. Drives compensatory hyperinsulinaemia, which stimulates ovarian androgen production.
- Chronic low-grade inflammation: Elevated CRP, IL-6, TNF-α, and oxidative stress markers are found consistently in PCOS. Inflammation amplifies insulin resistance and impairs follicular development.
- Androgen excess: Elevated testosterone and DHEAS — a downstream consequence of insulin-driven ovarian stimulation. Causes acne, hirsutism, and anovulation.
- Anovulation and cycle irregularity: The reproductive consequence of the above.
Spirulina is relevant primarily to the upstream mechanisms (insulin resistance and inflammation), not to androgen levels directly.
Mechanism 1: insulin sensitisation via phycocyanobilin
Phycocyanobilin (the chromophore of phycocyanin) is a potent inhibitor of NADPH oxidase — the enzyme that generates superoxide radical in response to insulin signalling in adipose tissue and muscle. NADPH oxidase-derived reactive oxygen species are a primary cause of insulin receptor serine phosphorylation (which reduces insulin sensitivity).
By inhibiting NADPH oxidase, phycocyanobilin reduces the oxidative stress that impairs insulin signalling. This is the same mechanism behind spirulina’s documented blood glucose and insulin sensitivity improvements in type 2 diabetes trials — directly relevant to the insulin resistance core of PCOS.
Mechanism 2: anti-inflammatory phycocyanin
PCOS’s chronic inflammatory state (elevated IL-6, TNF-α, NF-κB activation) is a target for phycocyanin’s direct NF-κB inhibition and COX-2 suppression. Reducing systemic inflammation in PCOS may break the feed-forward loop between inflammation and insulin resistance.
Several studies in PCOS patients show that interventions reducing systemic inflammation (omega-3 supplementation, anti-inflammatory diet, exercise) improve both inflammatory markers and insulin sensitivity simultaneously — consistent with the inflammation-insulin resistance axis.
Mechanism 3: GLA and hormonal balance
Gamma-linolenic acid (GLA) is an omega-6 fatty acid that generates anti-inflammatory PGE1 via prostaglandin synthesis. Evening primrose oil (rich in GLA) has been studied in PCOS, with some evidence for modest improvement in insulin resistance markers. Spirulina provides modest GLA (~30–60 mg per 5 g) as part of this pathway.
Iron and PCOS: a nuanced picture
Iron status in PCOS is complex:
- Women with PCOS and irregular or absent periods often have lower monthly iron loss than women with regular cycles — potentially higher iron stores
- However, chronic inflammation in PCOS upregulates hepcidin, which can cause functional iron deficiency despite adequate stores (iron sequestered in macrophages, unavailable for red cell production)
- PCOS is associated with a small but significant increase in ferritin levels above the normal range in some patients — likely related to the chronic inflammatory state
Practical implication: test ferritin before using spirulina as an iron source in PCOS. Some PCOS patients have elevated ferritin and should not add iron supplementation. Those with low or low-normal ferritin benefit from spirulina’s iron contribution.
Oxidative stress in PCOS
Oxidative stress is significantly elevated in PCOS — higher MDA (lipid peroxidation), lower glutathione, lower SOD than age-matched controls. Spirulina’s Nrf2 activation upregulates glutathione synthesis and SOD — directly addressing the oxidative burden of PCOS.
One small trial (2019, Kaviani et al.) in PCOS patients found spirulina supplementation (2 g/day × 8 weeks) improved antioxidant capacity and reduced MDA compared to placebo — the most directly relevant clinical evidence for PCOS specifically.
What spirulina does not address in PCOS
- Androgen excess directly: Spirulina has no anti-androgenic activity. It may reduce androgens indirectly if it improves insulin resistance (lower insulin = less ovarian androgen stimulation), but this is indirect and unproven in PCOS.
- Cycle regulation: Cycle normalisation in PCOS requires addressing the upstream androgen excess and insulin resistance; spirulina alone is insufficient.
- Metformin or inositol: These have the strongest evidence for improving insulin sensitivity and ovulation in PCOS. Spirulina does not replace them for women with significant insulin resistance requiring treatment.
Practical guidance for PCOS
- Test ferritin and CRP before starting — to establish whether iron supplementation is appropriate and to provide a baseline for assessing improvement
- 3–5 g/day is the appropriate dose range — consistent with the doses that show insulin sensitivity and anti-inflammatory effects in clinical trials
- 8–12 weeks is the minimum meaningful assessment period — consistent with the timeline for insulin sensitivity improvements
- Combine with the established PCOS interventions: low glycaemic index diet, regular exercise (the most evidence-supported PCOS intervention for insulin resistance), inositol (4 g/day myo-inositol has strong PCOS evidence), and medical treatment as prescribed